CERo Therapeutics Holdings, Inc.(CERO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CERO CERo Therapeutics Holdings, Inc.

Market Closed 02-14 16:00:00 EST

2.06

+0.26

+14.44%

盘后2.05

-0.01-0.49%

19:59 EST

High2.06	Low1.80	Vol320.27K
Open1.89	D1 Closing1.80	Amplitude14.38%
Mkt Cap6.24M	Tradable Cap5.05M	Total Shares3.03M
T/O622.78K	T/O Rate13.06%	Tradable Shares2.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CERO","market":"US","secType":"STK","nameCN":"CERo Therapeutics Holdings, Inc.","latestPrice":2.06,"timestamp":1739566800000,"preClose":1.8,"halted":0,"volume":320268,"hourTrading":{"tag":"盘后","latestPrice":2.0499,"preClose":2.06,"latestTime":"19:59 EST","volume":12024,"amount":24341.192,"timestamp":1739581194559},"delay":0,"floatShares":2453100,"shares":3029933,"eps":-27.8388,"marketStatus":"Market Closed","change":0.26,"latestTime":"02-14 16:00:00 EST","open":1.89,"high":2.06,"low":1.8011,"amount":622782.904224,"amplitude":0.143833,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-27.8388,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.8,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.8,"latestTime":"09:26 EST","volume":4400,"amount":7965.02696,"timestamp":1739543161340},"postHourTrading":{"tag":"盘后","latestPrice":2.0499,"preClose":2.06,"latestTime":"19:59 EST","volume":12024,"amount":24341.192,"timestamp":1739581194559},"volumeRatio":2.2149980632102744},"requestUrl":"/m/hq/s/CERO","defaultTab":"news","newsList":[{"id":"2509275525","title":"CERo Therapeutics Holdings, Inc. Highlights Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2509275525","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509275525?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:15","pubTimestamp":1738847700,"startTime":"0","endTime":"0","summary":"Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025. CEO Chris Ehrlich commented, “We have had a very strong entry into 2025, which has greatly improved the outlook of the Company from the previous year. As announced, we completed a $5 million financing, which gives us a current cash position of approximately $8 million. We believe this funding will allow us to achieve numerous value-creating milestones in the coming year. In addition, we have also completed the conversion of the majority of our preferred shares into common shares, which significantly improves our cap table moving forward.CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is desig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-holdings-inc-highlights-131500688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRGS","BK4139","CEROW","BK4097","CERO","LU2065732104.USD"],"gpt_icon":0},{"id":"2509260414","title":"Cero Therapeutics prices $5M at-the-market offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2509260414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509260414?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:40","pubTimestamp":1738806043,"startTime":"0","endTime":"0","summary":"CERo Therapeutics (CERO) announced the pricing of its “reasonable best efforts” public offering with participation from a member of the Company’s b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-prices-5m-at-the-market-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-prices-5m-at-the-market-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2509264124","title":"BRIEF-Cero Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2509264124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509264124?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:01","pubTimestamp":1738803665,"startTime":"0","endTime":"0","summary":"BRIEF-Cero Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq RulesFeb 5 (Reuters) - CERo Therapeutics Holdings Inc CERO.O:CERO THERAPEUTICS ANNOUNCES $5 MILLION PUBLI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA4NVVSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2509264369","title":"Cero Therapeutics Announces $5 Million Public Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2509264369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509264369?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:00","pubTimestamp":1738803600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA4NVVSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2509126492","title":"Cero Therapeutics Holdings Inc - Prices Public Offering at $1.96 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2509126492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509126492?lang=en_us&edition=fundamental","pubTime":"2025-02-06 09:00","pubTimestamp":1738803600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA4NVVSC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2505224592","title":"Cero Therapeutics Holdings Inc - on Jan 17, Nasdaq Grants Cero Therapeutics Extension to Regain Compliance Until April 22, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505224592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505224592?lang=en_us&edition=fundamental","pubTime":"2025-01-21 20:33","pubTimestamp":1737462825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nFWN3OH0O3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2505322375","title":"Cero Therapeutics Files for Offering up to 4 Mln Shares of Common Stock Together With 4 Mln New Common Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2505322375","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505322375?lang=en_us&edition=fundamental","pubTime":"2025-01-21 19:27","pubTimestamp":1737458855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nFWN3OH0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2501763335","title":"CERO Stock trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2501763335","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501763335?lang=en_us&edition=fundamental","pubTime":"2025-01-08 08:50","pubTimestamp":1736297426,"startTime":"0","endTime":"0","summary":"19:50 EST CERO Stock trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-stock-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-stock-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2501661209","title":"Cero Therapeutics to effect 1-for-100 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2501661209","media":"TipRanks","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501661209?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:13","pubTimestamp":1736255593,"startTime":"0","endTime":"0","summary":"CERo Therapeutics  announced that its board of directors has determined to effect a one-for-one hundred reverse stock split of the Company’s common stock, par value $0.0001 per share. The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 8, 2025, and the Company’s Common Stock will begin trading on a split-adjusted basis on The Nasdaq Global Market as of the opening of trading on January 8, 2025. The CUSIP number of 71902K303 will be assigned to the Company’s Common Stock when the reverse stock split becomes effective. When the reverse stock split becomes effective, every one hundred of the Company’s issued shares of Common Stock will be combined into one issued share of Common Stock, without any change to the par value per share. This will reduce the number of outstanding shares of Common Stock from approximately 260 million shares to approximately 2.6 million shares.Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Cero Therapeutic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cero-therapeutics-effect-1-100-131313162.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-effect-1-100-131313162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","CEROW","BK4139","CERO"],"gpt_icon":0},{"id":"2501239993","title":"BRIEF-Cero Therapeutics Holdings Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2501239993","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501239993?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:04","pubTimestamp":1736168695,"startTime":"0","endTime":"0","summary":"Jan 6 (Reuters) - CERo Therapeutics Holdings Inc :   * CERO THERAPEUTICS HOLDINGS, INC. ANNOUNCES REVERSE STOCK SPLIT   * CERO THERAPEUTICS HOLDINGS INC - ANNOUNCES ONE-FOR-ONE HUNDRED REVERSE STOCK SPLITSource text:   Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2501423933","title":"Cero Therapeutics Holdings, Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2501423933","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501423933?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:00","pubTimestamp":1736168401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA19JL85:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2501396542","title":"Cero Therapeutics Holdings Inc - Announces One-for-One Hundred Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2501396542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501396542?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:00","pubTimestamp":1736168401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUA19JL85:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2501239660","title":"CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2501239660","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501239660?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:00","pubTimestamp":1736168400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANSCISCO, Calif., Jan. 06, 2025  -- CERo Therapeutics Holdings, Inc.,   an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, today announced that its board of directors has determined to effect a one-for-one hundred reverse stock split of the Company’s common stock, par value $0.0001 per share .The reverse stock split will take effect at 12:01 a.m. Eastern Time on January 8, 2025, and the Company’s Common Stock will begin trading on a split-adjusted basis on The Nasdaq Global Market  as of the opening of trading on January 8, 2025. The CUSIP number of 71902K303 will be assigned to the Company’s Common Stock when the reverse stock split becomes effective.The reverse stock split ratio approved by the board of directors is within the previously disclosed range of ratios for a reverse stock s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-holdings-inc-announces-130000155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERO","QLD","CEROW","USJW.SI","NVIW.SI","TQQQ","USAW.SI","NQmain","TSYW.SI","QID",".IXIC","PSQ","SQQQ","MNQmain"],"gpt_icon":1},{"id":"2492797726","title":"Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2492797726","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492797726?lang=en_us&edition=fundamental","pubTime":"2024-12-18 17:34","pubTimestamp":1734514462,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42547912/why-corvus-pharmaceuticals-shares-are-trading-higher-by-around-22-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNQmain","NQmain","BK4583","BK4020","TNXP","EFSH","TSYW.SI","PRZO","QLD","BK4096","NUKK","CERO","NVIW.SI","BK4211","APDN","BK4161","BK4590",".IXIC","USAW.SI","BK4007","RR","SSBK","TQQQ","BK4157","KWE","QID","NIVF","PRTG","SHLT","PTPI","VSTE","BK4568","BK4097","COMM","BK4195","AUID","CRVS","BK4121","USJW.SI","BK4187","BK4006","BK4196","PSQ","WS","SQQQ","BK4023","FSBW"],"gpt_icon":1},{"id":"2489254261","title":"CERo Therapeutics Names Chris Ehrlich as Permanent CEO; Shares Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=2489254261","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489254261?lang=en_us&edition=fundamental","pubTime":"2024-12-06 23:48","pubTimestamp":1733500134,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Holdings (CERO) said Friday it appointed Chris Ehrlich as permanent chief executive, effective immediately.Ehrlich previously held the interim CEO role at the company.Shares of CERo Therapeutics slumped past 32% in recent trading.Price: 0.13, Change: -0.06, Percent Change: -32.06","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2489231500","title":"Cero Therapeutics appoints Chris Ehrlich as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231500","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489231500?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:35","pubTimestamp":1733495745,"startTime":"0","endTime":"0","summary":"Cero Therapeutics (CERO) announced its board of directors has appointed Chris Ehrlich as CEO. Previously he held the position of interim CEO. In ad...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-appoints-chris-ehrlich-as-ceo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-appoints-chris-ehrlich-as-ceo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CERO","LENZ","BK4139"],"gpt_icon":0},{"id":"2489233672","title":"Cero Therapeutics, Inc. Appoints Chris Ehrlich CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2489233672","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489233672?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:00","pubTimestamp":1733493600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nTUA3ZYSLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"2489233781","title":"CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2489233781","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489233781?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:00","pubTimestamp":1733493600,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif, Dec. 06, 2024  --  CERo Therapeutics Holdings, Inc.  , an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics augmented with phagocytic mechanisms derived from the innate arm of the immune system, announces its Board of Directors has appointed Chris Ehrlich as CEO. Previously he held the position of Interim CEO.In addition to his roles at CERo and LPAA, Mr.Ehrlich currently serves on the Healthcare at Kellogg Advisory Board at Northwestern University. He is the Principal of Ehrlich Bioventures, LLC, an advisory firm which assists emerging biopharmaceutical companies. He has a B.A. in Government from Dartmouth College and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T6sFa8GpShiuFtG._zLWDw--~B/aD00Mjk7dz04ODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d6252fbe33e9cbb1b271a88446c93bd3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T6sFa8GpShiuFtG._zLWDw--~B/aD00Mjk7dz04ODc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d6252fbe33e9cbb1b271a88446c93bd3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cero-therapeutics-inc-appoints-chris-140000838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERO","LENZ","CEROW","BK4139"],"gpt_icon":0},{"id":"2486384089","title":"Cero Therapeutics files to sell 210M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486384089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486384089?lang=en_us&edition=fundamental","pubTime":"2024-11-27 19:25","pubTimestamp":1732706708,"startTime":"0","endTime":"0","summary":"06:23 EST Cero Therapeutics (CERO) files to sell 210M shares of common stock for holders Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-files-to-sell-210m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cero-therapeutics-files-to-sell-210m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CERO","LENZ","BK4139"],"gpt_icon":0},{"id":"2486847869","title":"Cero Therapeutics Holdings - Potential Offer and Sale of up to 210 Mln Shares by Keystone Capital Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2486847869","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486847869?lang=en_us&edition=fundamental","pubTime":"2024-11-27 19:22","pubTimestamp":1732706571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY0N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CERO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cero.bio","stockEarnings":[{"period":"1week","weight":0.0619},{"period":"1month","weight":-0.2016},{"period":"3month","weight":-0.9278},{"period":"6month","weight":-0.8588},{"period":"1year","weight":-0.9958},{"period":"ytd","weight":-0.6567}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.154276},{"month":2,"riseRate":0.5,"avgChangeRate":-0.191254},{"month":3,"riseRate":1,"avgChangeRate":0.019563},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.170363},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.11752},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.223411},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.161759},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.060279},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.086633},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.023845},{"month":11,"riseRate":0.666667,"avgChangeRate":0.418767},{"month":12,"riseRate":0.5,"avgChangeRate":-0.169054}],"exchange":"NASDAQ","name":"CERo Therapeutics Holdings, Inc.","nameEN":"CERo Therapeutics Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CERo Therapeutics Holdings, Inc.(CERO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CERo Therapeutics Holdings, Inc.(CERO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CERo Therapeutics Holdings, Inc.,CERO,CERo Therapeutics Holdings, Inc.股票,CERo Therapeutics Holdings, Inc.股票老虎,CERo Therapeutics Holdings, Inc.股票老虎国际,CERo Therapeutics Holdings, Inc.行情,CERo Therapeutics Holdings, Inc.股票行情,CERo Therapeutics Holdings, Inc.股价,CERo Therapeutics Holdings, Inc.股市,CERo Therapeutics Holdings, Inc.股票价格,CERo Therapeutics Holdings, Inc.股票交易,CERo Therapeutics Holdings, Inc.股票购买,CERo Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CERo Therapeutics Holdings, Inc.(CERO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CERo Therapeutics Holdings, Inc.(CERO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}